On November 29, Hao Deming, Executive Vice President and Secretary-General of the Chinese Non-Government Medical Institutions Association (CNMIA), Mao Yan, Deputy Director of the Talent and Technical Services Department, and Zhao Lisha, Deputy Secretary-General of the Regenerative Medicine Branch (in preparation), visited Shenzhen Cell Valley for inspection and research. Our Chairman, Professor Shi Yuanyuan, Deputy General Manager Tang Xiaomeng, Commercial Director Wei Zheng, Head of Marketing Sun Rui, Head of Business Development Tang Hui, and Director of the General Administration Office Wang Lu extended a warm welcome and participated in the symposium.

With a detailed introduction by Commercial Director Wei Zheng, the visiting leaders toured the Shenzhen Cell Valley digital smart exhibition hall, gaining a deeper understanding of Cell Valley's strategic planning, the uniqueness of its core technologies, and future development trends. Subsequently, they visited the R&D, production, and quality management laboratories, obtaining a more intuitive appreciation of the operational processes and quality management systems.

During the symposium, Professor Shi Yuanyuan first extended a warm welcome to the visiting leaders and expressed sincere gratitude for their presence. Subsequently, Director Sun Rui provided a detailed introduction to the current state of the cell therapy industry, Shenzhen Cell Valley's industrial layout in cell and gene therapy, and its research and product portfolio.

Professor Shi Yuanyuan noted that recently, many regions have successively released policies to promote the cell therapy industry. As a multi-billion-dollar health industry, cell therapy has entered an accelerated development phase. Shenzhen Cell Valley will closely follow policy trends, provide comprehensive services for product R&D and result translation, fully leverage its advanced technologies and talent reserve, contribute to the development of the cell and gene therapy industry chain, and strive to make positive contributions to the highquality development of China's cell and gene therapy industry.

President Hao Deming further introduced during the symposium that the CNMIA headquarters is based in Beijing. As a national, industry-based, non-profit independent legal entity, it is China's only nationallevel industry organization dedicated to industry services and management for non-government medical and health institutions. Currently, the association has over 500,000 medical institutions nationwide, including more than 26,000 hospitals, accounting for 70% of the total hospitals in China, making it the largest and most influential nationallevel medical and health industry association in China and even globally.

The purpose of this visit was to gain insight into national policy directions, grasp industry development trends, and clarify the industry's development trajectory through exchanges with member institutions of the CNMIA, while also exploring the potential role and cooperation opportunities of nongovernment medical institutions in the cell therapy field, jointly promoting the healthy development of China's cell therapy industry.

(Group photo)

About the Chinese Non-Government Medical Institutions Association (CNMIA)

The Chinese Non-Government Medical Institutions Association (CNMIA) was established in Beijing in 2014 with the approval of the State Council. It is a national, industry-based, non-profit independent legal entity voluntarily formed by non-government medical and health institutions that have obtained legally issued medical practice licenses, relevant enterprises and public institutions, social organizations, and individuals. It is the only national-level industry organization in China dedicated to industry services and management for non-government medical and health institutions. The association's functions include industry service guidance, self-regulation, rights protection, and supervision and management, serving as a bridge and link between the government and non-government medical institutions. It is committed to promoting and guiding the development of non-government medical institutions nationwide, reflecting industry needs, and safeguarding industry rights. Against the backdrop of the rapid development of the cell therapy industry, the association actively fulfills its functions by organizing exchanges, providing information platforms, and conducting industry uations, offering services to member units and individuals, while also providing scientific and objective foundations for the formulation and implementation of national policies.